La Jolla, CA, United States of America

Vanessa Herrera

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Vanessa Herrera in Viral Vector Technology

Introduction

Vanessa Herrera is an accomplished inventor based in La Jolla, California. She has made significant contributions to the field of viral vector technology, particularly in the development of innovative compositions for medical applications. Her work focuses on enhancing the delivery and efficacy of viral particles for therapeutic purposes.

Latest Patents

Vanessa holds 1 patent for her invention titled "Composition of viral vectors in lecithin liposomes, preparation method and treatment methods." This patent describes a composition that includes a recombinant viral particle encapsulated within an anionic liposome made of lecithin and polyethylene glycol (PEG). The invention also outlines methods for preparing and purifying these encapsulated viral particles, as well as treatment methods for patients utilizing this technology.

Career Highlights

Vanessa is affiliated with the University of California, where she conducts her research and development work. Her innovative approach to viral vector technology has positioned her as a key figure in her field. She is dedicated to advancing medical treatments through her research.

Collaborations

Vanessa collaborates with notable colleagues, including Sarah L. Blair and Andrew C. Kummel. These partnerships enhance her research efforts and contribute to the advancement of her innovative projects.

Conclusion

Vanessa Herrera's work in viral vector technology exemplifies the impact of innovation in the medical field. Her contributions are paving the way for new treatment methods that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…